• Pharmicell controlling shareholder Kim Hyun Soo kept his stake unchanged at 7,033,144 shares, or 11.72%, as of Oct. 8, 2026.
• Disclosure was triggered by an extension of a share pledge covering 399,003 shares, or 0.66%, dated Oct. 6, 2026.
• The pledge supports a KRW 2.4 billion stock-backed loan with a 5.5% interest rate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmicell Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000414), on October 08, 2026, and is solely responsible for the information contained therein.